Judy Chertok, MD is an Associate Professor of Family Medicine and Community Health and the Director of Addiction Medicine and the Fellowship in Addiction Medicine in the Department of Family Medicine and Community Health at the University of Pennsylvania. Her clinical work is in primary care based opioid treatment, community-based low barrier opioid treatment, and specialty hospital-consultation addiction treatment in addition to general family medicine inpatient and outpatient. As the Director of Addiction Medicine, she initiated and oversaw the growth of the Medication for Opioid Use Disorder (MOUD) program within Penn Family Care, from a single patient to nearly 250 patients per year, including a novel perinatal program. Since 2020, she has joined a unique collaboration with Prevention Point Philadelphia to provide mobile harm reduction resources, MOUD and COVID vaccines in a low barrier, community setting. Her educational work is focused on incorporating training for addiction care throughout all four years of the Perelman School of Medicine, for residents in Family Medicine, and for Addiction Fellows.
Dr. Bonnie Milas is a clinical professor of anesthesiology & critical care medicine at the University of Pennsylvania. Her clinical practice involves caring for patients undergoing cardio-pulmonary surgical procedures, with expertise in transesophageal echocardiography. As an intensivist she also cares for these patients in the intensive care unit following surgery. She deals with the ravages of infected heart valves from intravenous drug use, and handles the post-operative management of opioid withdrawal and pain control.
Dr. Milas is an outspoken advocate for those suffering from opioid use disorder. She is painfully aware as she has lost both sons to this disease. Dr. Milas has published opinion pieces in the Philadelphia Inquirer and USA Today in an effort to reduce social stigma. Through her work locally with the Bucks Co. Drug and Alcohol Commission and nationally with the American Society of Anesthesiologists she is an ardent educator of naloxone overdose rescue with REVIVEme.com. Dr. Milas is the Chief Narcan Rescue Officer at her institution. She is a Friend of SafeHouse-the safe injection site given the legal go-ahead in Philadelphia. She testified before the Philadelphia city council to support the SafeHouse effort. Most recently, she provided personal testimony at the FDA in support of over the counter naloxone access, which received final approval March, 2023. Dr. Milas is committed to saving lives of those suffering with OUD.
Michael A. Ashburn, MD, MPH, MBA
Dr. Ashburn is professor of Anesthesiology and Critical Care and a Senior Fellow of the Leonard Davis Institute of Health Economics at the University of Pennsylvania. He is the Director of the Penn Pain Medicine Center and was named to the Penn Academy of Master Clinicians in 2014.
Dr. Ashburn completed his undergraduate training at Auburn University in physics, his MPH at the University of Utah, his MBA at the Wharton School of Business at the University of Pennsylvania, and his medical training at the University of South Alabama in Mobile, Alabama. He completed his residency in anesthesiology at the University of South Alabama Medical Center, and a fellowship in pain medicine at the University of Utah. He is board certified in Anesthesiology, Pain Management, Hospice and Palliative Medicine through the American Board of Anesthesiology, and in Addiction Medicine through the American Board of Preventive Medicine.
Dr. Ashburn was a member of the Department of Anesthesiology at the University of Utah from 1987 – 2002 and served as Professor of Anesthesiology and Director of the Pain Management Center from 1996 – 2002. Dr. Ashburn was president of the American Pain Society from 2000 – 2002. In addition, Dr. Ashburn served on the Board of Directors of the Rehabilitation Accreditation Commission, (CARF) from 2001-2003, where he served as a member of 3 National Advisory Committees on Pain. Prior to joining the faculty at the University of Pennsylvania in 2007, Dr. Ashburn was the co-founder and Executive Vice President for Clinical and Regulatory Affairs for ZARS Pharma of Salt Lake City.
Dr. Ashburn was a Robert Wood Johnson Health Policy Fellow from 1995 – 1996, where he served as a health policy advisor for Senator Orrin Hatch (R, UT) in Washington, DC. He served as the Chairman of the Pain Care Coalition from 2000-2002, and as the chair of the Pennsylvania Pain Coalition from 2009 to 2012. Dr. Ashburn has served as an expert witness for the Drug Enforcement Agency, Federal Bureau of Investigation, and Department of Justice, as well as the states of Maryland and Pennsylvania.
Dr. Ashburn served on the Pennsylvania House Advisory Committee on Opioid Addiction (2014- 2015), the Pennsylvania task force to develop core competencies for the prevention and management of prescription drug abuse for use by Pennsylvania medical schools (2016- 2017), and the Pennsylvania Legislative Advisory Committee on Addiction Treatment Services (2016 – 2018). Dr. Ashburn currently serves on the Pennsylvania State Task Force on Prescription Drug Abuse, the Advisory Board for the Pennsylvania Prescription Drug Monitoring Database, and co-chairs the University of Pennsylvania Health System Opioid Task Force.
Dr. Ashburn serves on the editorial board for Pain Medicine and The Journal of Opioid Management. He has been active in clinical research, mainly centered on the development of outcome measurement systems for chronic pain and palliative care, the integration of specialty care into primary care practice through the patient-centered medical home model of care, the study of non-invasive drug delivery systems, and the conduct of safety and efficacy trials intended to evaluate a drug or device for the treatment of pain.
Sara S. Bachman, Ph.D. is Dean of the School of Social Policy & Practice at the University of Pennsylvania. She is an expert in health care financing and organization, with a particular focus on alternative payment strategies. Dr. Bachman has over twenty-five years’ experience with health policy research and program evaluation, especially in the area of health care finance, health reform, social work, state health policy for individuals with disabilities or complex health and social conditions, including children and youth with special health care needs, working age adults, and individuals who are dually eligible for Medicare and Medicaid. Previously she led a large grant funded research and policy analysis center, where she directed many projects. For example, she served as the Principal Investigator for the Catalyst Center, the national center funded to improve financing of care for children with special health care needs. Dr. Bachman has extensive experience in matters related to the protection of human subjects in research, having served as the faculty chair of an Institutional Review Board. Dr. Bachman received her Ph.D. in Health Policy from Brandeis University’s Florence Heller School where she was a Pew Health Policy Fellow. Dr. Bachman also has an M.S. in Epidemiology from the University of Massachusetts School of Public Health, and this perspective has informed her approach to understanding disability and public health issues.
Dr. Compton is an Associate Professor and the van Ameringen Endowed Chair in the
Department of Family and Community Health at the University of Pennsylvania School
of Nursing. She is a Fellow of the American Academy of Nursing and an elected
member of the International Association in the Study of Pain, and the College on
Problems of Drug Dependence. Her area of clinical expertise is the intersection of
opioids, addiction and pain. The unifying theme of her program of research is the
understanding of pain responses in individuals who abuse or are addicted to opioids, licit
or otherwise, and her novel data have contributed to a growing body of literature on the
phenomenon of opioid-induced hyperalgesia, as well as informed guidelines for the
management of pain in persons with opioid addiction or on maintenance opioid therapy.
Complementing Dr. Compton’s expertise in the pain responses of opioid addicts is her
clinical work establishing methods to identify substance use disorders and addiction in
chronic pain patients on ongoing opioid analgesic therapy. She has published extensively
in the scientific literature on substance use disorder in chronic pain patients on opioid
therapy, and the pain responses of opioid addicts with and without chronic pain. Her role
as teacher, researcher, and mentor is strengthened by interdisciplinary research
collaborations with the NIDA Center for Studies of Addiction at the Perelman School of
Medicine, the Penn Pain Medicine Center in the Department of Anesthesiology at the
University of Pennsylvania Health Systems, and the University of Pennsylvania NIH
Center of Excellence in Pain Education (COEPE). Having worked in several public
treatment settings, she is expert in the use of methadone, buprenorphine and naltrexone in
the treatment of opioid use disorder. She has served on FDA, SAMHSA and NIH expert
panels on prescription opioid abuse, and contributed to position statements from the
American Pain Society, College on Problems of Drug Dependence, and the American
Society of Pain Management Nurses on pain management for patients with addictive
disease. She currently serves as principal investigator on a NIDA-supported grant
exploring hyperalgesic responses in individuals undergoing opioid taper.
Deborah A. Driscoll, MD
Senior Vice President, Clinical Practices of the University of
Vice Dean for Professional Services, Perelman School of Medicine
Luigi Mastroianni, Jr. Professor of Obstetrics and Gynecology
Deborah A. Driscoll, MD was appointed Senior Vice-President for
the Clinical Practices of the University of Pennsylvania and Vice
Dean for Professional Services at the Perelman School of Medicine
in October 2019 after serving as Chair of the Department of
Obstetrics and Gynecology and Director of the Center for Research
on Reproduction and Women’s Health for 14 years. She maintains a clinical practice in the
Divisions of Reproductive Genetics and Maternal Fetal Medicine at the Hospital of the
University of Pennsylvania.
A graduate of Smith College and New York University School of Medicine, she completed a
residency in Obstetrics and Gynecology at the Hospital of the University of Pennsylvania and a
fellowship in Clinical and Molecular Genetics at the University of Pennsylvania. Dr. Driscoll is
internationally known for her research on the 22q11.2 deletion syndrome and for her expertise
on genetic screening and the care of women with genetic conditions. Dr. Driscoll was the
principle investigator of the NICHD Women’s Reproductive Health Research (WRHR) career
development program and the March of Dimes Prematurity Research Center at the University
of Pennsylvania. She is the recipient of several awards including a Lindback Award for
Distinguished Teaching, AAMC Women in Medicine and Science Leadership award, FOCUS
Award for the Advancement of Women in Medicine, and the Perelman School of Medicine
Elizabeth Kirk Rose, MD Women in Medicine award and the Alumni Service award. Dr. Driscoll
has served on numerous committees for the University of Pennsylvania Health System and as
chair of CPUP Clinical Operations Committee and chair of the Hospital of the University of
Pennsylvania Medical Board. Nationally, she has served as Treasurer of the American College of
Medical Genetics, President of the Council of University Chairs in Obstetrics and Gynecology
and President of the American Board of Obstetrics and Gynecology. She is a member of the
National Academy of Medicine and an honorary fellow of the Royal College of Obstetricians and
Lee A. Fleisher, MD, is the Robert D. Dripps Professor and Chair of Anesthesiology and Critical Care and Professor of Medicine at the University of Pennsylvania Perelman School of Medicine from which he received the 2016 Lindback Award for Distinguished Teaching. He received his medical degree from the State University of New York at Stony Brook. His research focuses on perioperative cardiovascular risk assessment and reduction, measurement of quality of care, decision making, implementation of cultural change and health policy. He has received numerous federal, industry and foundation grants and has published 163+ original articles, over 200 editorials, reviews and book chapters, and 9 books and collaborates with anthropologists, sociologists, as well as faculty from law, business and nursing.
He is co-chair of the Surgery Standing Committee, former member of the Measures Application Partnership Hospital Workgroup and Treasurer of the Board of Directors of the National Quality Forum. He is a member of the Care Transformation Forum (CTF) of the Health Care Payment Learning and Action Network (LAN). He is the current Chair of the Ambulatory Surgery Center Technical Expert Panel of the Leapfrog Group and a member of the Medical Advisory Panel for the Technology Evaluation Center of the Blue Cross/Blue Shield Association and the Task Force on Practice Guidelines for the American College of Cardiology/American Heart Association. In 2007, he was elected to membership of the National Academy of Medicine (formerly Institute of Medicine) of the National Academy of Sciences and serves on Committees of the NAM.
Heather Klusaritz, PhD, MSW
Director of Community Engagement, Penn Center for Public Health Initiatives
Community Engagement Chair, Penn Medicine Center for Health Equity Advancement
Associate Director, Center for Community & Population Health, Department of Family Medicine &
Heather Klusaritz, PhD, MSW is the Director of Community Engagement for the Penn Center for Public Health Initiatives and the Associate Director of the Center for Community and Population Health in the Department of Family Medicine and Community Health, Perelman School of Medicine. Dr. Klusaritz holds faculty appointments in the Department of Family Medicine and Community Health, the Masters of Public Health program, and the School of Social Policy and Practice at the University of Pennsylvania. Dr. Klusaritz has worked clinically as a member of interdisciplinary care teams treating vulnerable populations at the Penn Medicine for almost 20 years. Her research interests focus on access to health care for marginalized populations and the design of health systems to eliminate disparities in health access and outcomes. Currently, Dr. Klusaritz co-directs the HRSA-funded National Center for Integrated Behavioral Health that aims to generate best practices of scalable inter-professional integrated behavioral health training in primary care, and is a Co-Investigator of a Community Medicine Leadership Fellowship within a geographic care network of primary care provider champions and educators who share complex and high utilizing patients. Dr. Klusaritz has done extensive work on patient-centered medical home and played important roles in practice transformation including screening for and addressing social determinants of health. Dr. Klusaritz works collaboratively with multiple community partners throughout West Philadelphia to improve the health of underserved communities and is the co-founder of a program that connects patients to critical social welfare benefits, helps navigate health system access, and engages in medical-legal advocacy.
Dr. Oquendo is Professor and Chairman of Psychiatry at University of Pennsylvania. Her medical education is from Columbia University and Payne Whitney Clinic, New York Hospital Cornell. She is a member of the National Academy of Medicine, one of the highest honors in medicine. Dr. Oquendo uses multimodal imaging to map brain abnormalities in mood disorders and suicidal behavior. Her expertise ranges from psychopharmacology to Global Mental Health, with over 385 peer-reviewed publications. Dr. Oquendo is Past President of APA and the International Academy of Suicide Research and chairs the American Foundation for Suicide Prevention’s Scientific Board of Directors. She is President-Elect of the American College of Neuropsychopharmacology.
Karen M. Puopolo, M.D., Ph.D. is a neonatologist who specializes in neonatal infectious diseases.
Dr. Puopolo is an Associate Professor of Pediatrics on the faculty of the University of Pennsylvania
Perelman School of Medicine. She is a member of the Division of Neonatology at The Children’s
Hospital of Philadelphia, and Section Chief for Newborn Medicine at Pennsylvania Hospital. Dr.
Puopolo received her undergraduate degree in physics from Yale University, and went on to obtain
her M.D. as well as a Ph.D. in molecular physiology from the Tufts University School of Medicine
in Boston. She completed Pediatric residency and Neonatal-Perinatal fellowship training at Boston
Children’s Hospital. Dr. Puopolo was appointed to the faculty of Harvard Medical School from
2000-2014 where she was a physician and researcher at the Brigham and Women’s Hospital and the
Channing Laboratory. She began her neonatal research career as a laboratory-based scientist
investigating mechanisms of virulence in Group B Streptococcus. Her current research focuses on
neonatal sepsis epidemiology and risk assessment. In collaboration with Dr. Gabriel Escobar, she
developed and validated models to quantify the risk of neonatal early-onset sepsis. She is currently
funded by the National Institutes of Health and the CDC to study the impact of neonatal antibiotic
exposures on the newborn and early childhood microbiome, and on infant and early childhood
growth. Dr. Puopolo is a member of the American Academy of Pediatrics Committee on the Fetus